CATALAYER NEWS
MetaVia reports 68% liver fat reduction in phase 1 trial
Source: Investing.com · 2026-11-05
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Cantor Fitzgerald lowers MercadoLibre stock price target on margin concerns
2026-11-05
RBC cuts Cava stock price target on Q3 miss, maintains Outperform
2026-11-05
RBC raises McDonald’s stock price target to $300 on sales momentum
2026-11-05
Reaves Utility Income Fund stock hits 52-week low at 33.5 USD
2026-11-05
Ivanhoe Electric stock hits 52-week low at 7.41 USD
2026-11-05
RELATED MARKETS
Prediction Markets